OncoStem Diagnostics Competitors and Similar CompaniesClear all

OncoStem Diagnostics's competitors and similar companies include Sesen Bio, Mirati Therapeutics, Delcath Systems and Infinity Pharmaceuticals.
OncoStem Diagnostics
OncoStem Diagnostics
OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
Sesen Bio
Sesen Bio
Sesen Bio (formerly Eleven Biotherapeutics) is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics.
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
Delcath Systems
Delcath Systems
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
Infinity Pharmaceuticals
Infinity Pharmaceuticals
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Founding Date
Founding Date
2011
Founding Date
2010
Founding Date
2013
Founding Date
1988
Founding Date
2000
Type
Type
Private
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Bengaluru, IN HQ
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Zug, CH
Locations
New York, US HQ
Galway, IE
Queensbury, US
Locations
Cambridge, US HQ
Employees
Employees
235% increase
Employees
254% increase
Employees
2812% decrease
Employees
437% decrease
Employees
25
Valuation ($)
Valuation ($)
N/A
Valuation ($)
127.5 m
Valuation ($)
N/A
Valuation ($)
196.4 m
Valuation ($)
726.1 k
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
413
Twitter followers
2.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.9m (FY, 2023)
Revenue (est.)
$12.4m (FY, 2022)
Revenue (est.)
$2.1m (FY, 2023)
Revenue (est.)
$2.6m (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$600k (FY, 2022)
Cost of goods
$635k (FY, 2023)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$11.8m (FY, 2022)
Gross profit
$1.4m (FY, 2023)
Gross profit
N/A
Net income
Net income
N/A
Net income
($86.9m) (FY, 2023)
Net income
($740.9m) (FY, 2022)
Net income
($47.7m) (FY, 2023)
Net income
($44.4m) (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 7m
Total funding raised
$ 55m
Total funding raised
N/A
Total funding raised
$ 42m
Total funding raised
$ 106.6m
For sources of this data, please see the company profile

View Company Profiles

Sesen Bio
HQ
Cambridge, US
Employees
25↑ 4% increase

Sesen Bio (formerly Eleven Biotherapeutics) is a biologics oncology company focused on the development of novel therapies based upon tumor targeting antibody fragments genetically fused to a cytotoxic protein payload called Targeted Protein Therapeutics.

View company
Mirati Therapeutics
HQ
San Diego, US

Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.

View company
Delcath Systems
HQ
New York, US
Employees
43↓ 7% decrease

Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.

View company
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
25

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

View company